-
-
-
-
-
-
-
Aequus Provides General Update and Fiscal 2022 Financial Results
-
-
-
-
-
-
-
Press Release for Early Warning Report Regarding Aequus Pharmaceuticals Inc.
-
-
-
-
-
-
-
Aequus Announces Director Resignation
-
-
-
-
-
-
-
Aequus and reVision to Collaborate on Stargardt Disease Program
-
-
-
-
-
-
-
Aequus Announces Notice of Warrant Acceleration
-
-
-
-
-
-
-
Aequus Receives Approval for New ‘Evolve - Daily Intensive’ Lubricating Eye Drops in Canada
-
-
-
-
-
-
-
Amendment on Earlier Release: Aequus Provides General Update and First Quarter 2020 Financial Highlights
-
1,170,840 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

